Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model
- PMID: 25449459
- DOI: 10.1016/j.jep.2014.11.013
Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model
Abstract
Ethnopharmacological relevance: Shexiang Tongxin dropping pill (STDP) is a formulation of Traditional Chinese Medicine mainly used for clinical treatment of stable angina pectoris in China.
Aim of the study: To investigate the effects and mechanisms of STDP treatment on atherosclerosis.
Materials and methods: ApoE deficient (ApoE(-/-)) mice were utilized to evaluate the effect of STDP treatment (30 mg/kg/day) on atherosclerotic lesions. Histopathological features of atherosclerotic lesions, serum levels of lipid proteins, parameters of oxidative stress and pro-inflammatory cytokines were measured by H&E staining, Masson's trichrome staining and ELISA, respectively. Real-time PCR analyses were performed to examine the aortic expression of atherosclerosis-associated microRNAs.
Results: The STDP treatment resulted in attenuated atherosclerotic lesion manifested by reduced lipid deposition, fibrosis and oxidative stress. It also led to increase in serum levels of GSH and SOD, decrease in MDA, decrease in CHO, TG, LDL, ox-LDL and increase in HDL, respectively. Additionally, the levels of pro-inflammatory cytokines including IL-2, IL-6, TNF-α and γ-IFN were markedly reduced by STDP treatment. Furthermore, STDP treatment was associated with a significant reduction in the aortic expression of miR-21a, miR-132, miR-126a, miR-155 and increased expression of miR-20a.
Conclusion: Our results demonstrated for the first time that STDP attenuated atherosclerotic lesions in ApoE(-/-) mouse model. Moreover, STDP treatment exhibited multi-targeting effects on pathological, biochemical and molecular aspects of atherosclerosis implicating lipid regulation, fibrosis, inflammation and oxidative stress. Findings from the current study warrant further evaluation of the clinical application of STDP in atherosclerosis treatment.
Keywords: Atherosclerosis; Inflammation; Oxidative stress; Shexiang Tongxin dropping pill; microRNA.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.Cardiovasc Hematol Agents Med Chem. 2018;16(2):74-80. doi: 10.2174/1871525717666181211110332. Cardiovasc Hematol Agents Med Chem. 2018. PMID: 30526472 Review.
-
Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.Lipids Health Dis. 2018 Jul 31;17(1):182. doi: 10.1186/s12944-018-0823-4. Lipids Health Dis. 2018. PMID: 30064511 Free PMC article.
-
Xiaoxianggou attenuates atherosclerotic plaque formation in endogenous high Ang II ApoE(-/-) mice via the inhibition of miR-203 on the expression of Ets-2 in endothelial cells.Biomed Pharmacother. 2016 Aug;82:173-9. doi: 10.1016/j.biopha.2016.04.065. Epub 2016 May 9. Biomed Pharmacother. 2016. PMID: 27470353
-
[Anti-atherosclerotic Effects of Bear Bile Powder in Shexiang Tongxin Dripping Pill: a Mechanism Study].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Sep;35(9):1083-9. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26591364 Chinese.
-
Anti-atherosclerotic molecules targeting oxidative stress and inflammation.Curr Pharm Des. 2009;15(27):3094-107. doi: 10.2174/138161209789058048. Curr Pharm Des. 2009. PMID: 19754384 Review.
Cited by
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Shexiang Tongxin Dropping Pill Allieviates Heart Failure via Extracellula Matrix-Receptor Interaction Pathways Based on RNA-Seq Transcriptomics and Experimental Studies.Chin J Integr Med. 2023 Jul;29(7):600-607. doi: 10.1007/s11655-023-3633-0. Epub 2023 Mar 26. Chin J Integr Med. 2023. PMID: 36971884
-
Efficacy of Shexiang Tongxin Dropping Pills in a Swine Model of Coronary Slow Flow.Front Physiol. 2022 Jun 14;13:913399. doi: 10.3389/fphys.2022.913399. eCollection 2022. Front Physiol. 2022. PMID: 35774283 Free PMC article.
-
Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review.Evid Based Complement Alternat Med. 2021 Nov 27;2021:4010607. doi: 10.1155/2021/4010607. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34873408 Free PMC article. Review.
-
Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System.Front Pharmacol. 2021 Nov 2;12:751487. doi: 10.3389/fphar.2021.751487. eCollection 2021. Front Pharmacol. 2021. PMID: 34795586 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous